Hansen Medical, Inc., a global leader in intravascular robotics, today announced it will exhibit its Magellan™ Robotic System at two upcoming interventional meetings in Europe. Hansen will be exhibiting Magellan at Booth 25 for the Controversies and Updates in Vascular Surgery (CACVS) Meeting in Paris, France from January 23 - 25; and at Booth 4 for the Leipzig Interventional Course (LINC) in Leipzig, Germany from January 28 - 31.
Multiple physicians are scheduled to give presentations about their experiences with Magellan at these meetings. Dr. Frederic Cochennec of Henri Mondor Hospital in Créteil, France will speak about his center's experiences with Magellan on Friday, January 24 at 8:40 a.m. Two additional presentations are scheduled for LINC. Professor Nick Cheshire, medical director at Imperial College Healthcare NHS Trust in London, will present a session titled "Can robotic assistance be helpful to navigate through complex arch anatomies and make CAS safer?" on Tuesday, January 28 at 5:40 p.m.; and Dr. Thomas Nolte, Director of Vascular Center, Heart & Vascular Center, Bad Bevensen, Germany will present "Robotic routing in complex aortic intervention" during the moderated poster presentation session on Wednesday, January 29 at 10:20 a.m.
"We are excited to showcase the Magellan Robotic System at these important global conferences," said Bruce Barclay, president and CEO of Hansen Medical. "Approximately 5,000 interventionalists from around the world are expected to attend these two meetings, and these presentations by physicians representing multiple European institutions will provide important information to the interventional community about the clinical value Magellan is delivering in a wide variety of peripheral vascular procedures."
About the Magellan™ Robotic System
Hansen Medical's Magellan Robotic System is intended to be used to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices. The Magellan System is designed to deliver predictability to simple and complex endovascular procedures. Since its commercial introduction in the U.S. and Europe, the Magellan System has demonstrated its clinical versatility in many cases in a broad variety of peripheral vascular procedure types in centers across the US and Europe. The system is based upon the flexible robotic technology incorporated in the Sensei-X® Robotic Catheter System currently sold in the U.S. and Europe, which has been used in nearly 13,000 patients, but includes a number of key enhancements. In particular, the Magellan Robotic System:
- Provides solid catheter stability for placement of therapeutic devices.
- Is designed to enable predictable procedure times and increased case throughput.
- Allows for independent, individual robotic control of the distal tips of both the outer sheath and the inner leader catheter, as well as robotic manipulation of standard guidewires.
- Is designed to allow for sufficient extension inside the body to access hard to reach peripheral anatomy.
- Preserves the open architecture featured in the Sensei System to allow for the subsequent use of many 6F therapeutic devices on the market today.
- Is designed to potentially reduce physician radiation exposure and fatigue by employing a remote physician workstation.
Source: http://www.hansenmedical.com/